PMPN_Pharmaceutical & Medical Packaging News

Pharmaceutical & Medical Packaging News, November/December 2014

Issue link: http://dc.cn.ubm-us.com/i/431261

Contents of this Issue

Navigation

Page 28 of 43

29 November/December 2014 Pharmaceutical & Medical Packaging News • pmpnews.com Similarly, among the new packag- ing and labeling services Fisher Clinical Services has introduced for clinical-trial materials is a series of manual, semi-auto- mated, and fully automated methods for prefilled syringe assembly and labeling. Fisher's ProSyries Syringe Assembly and Labeling services accelerate production and improve quality con- trol, Harrington says. The fully automated method, he adds, triples the num- ber of syringes that can be packaged and labeled in a daily shift compared to manual procedures. PCI's Misher cites PCI's use of validated vision systems as one good example of how the company's clinical-trials endeavors benefit from automation. "Let's say we have a study that includes an active and a placebo," Misher begins. "And we need to blister that product first, then place the blisters into wallet cards. Let's say that one of the treatment groups requires one blister's being active and one's being a placebo to achieve the specified dosing strength. We must ensure when we put those wallets together we truly have an active and a placebo blister in that card and in the right position before it's sealed and labeled. "The way we do that," Misher con- tinues, "is we print a 2-D Data Matrix code on the back of that blister that uniquely identifies its product as active or placebo. When that blister is loaded into the wallet card, there is a vision system that will then look at those two blisters, read that bar code, and verify that yes, the bar code is correct for the placebo, and the placebo is in its right location in the card—which may be critical for dosing purposes." This is done for each and every package for the study, ensuring the safety and efcacy of the drug for each patient. On the information-technology side, Catalent recently made what Trochu describes as "significant additional investments" in its "e-clinical trials" More studies are testing biological drugs that require frozen storage down to -80°C. Image from Fisher Clinical Services. PRINT: UDI-GS1 Serialized Codes, Logos, Barcodes, Variable Data, Product Info, Graphics & much more on a wide range of materials directly on your packaging line w w w . B E L L - M A R K . c o m 9 7 3 - 8 8 2 - 0 2 0 2

Articles in this issue

Links on this page

Archives of this issue

view archives of PMPN_Pharmaceutical & Medical Packaging News - Pharmaceutical & Medical Packaging News, November/December 2014